GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » Change In Payables And Accrued Expense

Guobang Pharma (SHSE:605507) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Guobang Pharma Change In Payables And Accrued Expense?

Guobang Pharma's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Guobang Pharma's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Guobang Pharma's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0 Mil. It means Guobang Pharma's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Guobang Pharma Change In Payables And Accrued Expense Historical Data

The historical data trend for Guobang Pharma's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guobang Pharma Change In Payables And Accrued Expense Chart

Guobang Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

Guobang Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Guobang Pharma Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guobang Pharma Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Guobang Pharma's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Guobang Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
SZSE:301263 SZSE:002317 SZSE:002020 SHSE:600572 SHSE:600211 SHSE:600267 SZSE:300026 SZSE:300119 SHSE:603567 SHSE:600129 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 60, Xingmei Avenue, Provincial High-tech Industrial Park, Zhejiang Province, Xinchang, CHN, 312500
Website
http://www.gbgcn.com
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.

Guobang Pharma Headlines

No Headlines